squamous cell carcinoma

You have access
Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study
TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, KUNIHIKO TOKASHIKI, HIDEAKI TAKAHASHI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, TATSUO MASUBUCHI, YUICHIRO TADA, KOKI MIURA, GO OMURA, TAKU YAMASHITA, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA

Anticancer Research June 2023, 43 (6) 2717-2724; DOI: https://doi.org/10.21873/anticanres.16438
Open Access
CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma
YUHEI MIYASAKA, YUYA YOSHIMOTO, KEN ANDO, KAZUTOSHI MURATA, DAISUKE IRIE, HIRO SATO, SHIN-EI NODA, HAYATO IKOTA, TAKASHI NAKANO, HIDEAKI YOKOO and TATSUYA OHNO

Anticancer Research May 2023, 43 (5) 2077-2084; DOI: https://doi.org/10.21873/anticanres.16368
You have access
Real-world Data Study of the Efficacy and Toxicity of Nivolumab vs. Cetuximab and Predictors of Response to Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck in a European Population
LOLA MACIA-RIVAS, CLARA LUZ FERNANDEZ-LAGUNA, CRISTINA ALVAREZ-ASTEINZA, IVAN MARAY, MONICA CARBAJALES-ALVAREZ and ANA LOZANO-BLAZQUEZ

Anticancer Research April 2023, 43 (4) 1681-1688; DOI: https://doi.org/10.21873/anticanres.16320
Open Access
Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
PASCALE ALICIA HOELL, KHALED ELSAYAD, HENDRIK BERSSENBRUEGGE, DOMINIK HERING, CHRISTOPHER KITTEL, JOHANNES KLEINHEINZ, ANNALEN BLECKMANN, GEORG EVERS, EVA WARDELMANN, CLAUDIA RUDACK and HANS THEODOR EICH

Anticancer Research March 2023, 43 (3) 1255-1263; DOI: https://doi.org/10.21873/anticanres.16272
You have access
Papillary Thyroid Carcinoma With Squamous Dedifferentiation: A Potential Diagnostic Pitfall
KOMAL IJAZ and FENG YIN

Anticancer Research January 2023, 43 (1) 255-258; DOI: https://doi.org/10.21873/anticanres.16157
You have access
Treatment Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and Fluorouracil in Advanced Head and Neck Cancer
TAKAHIRO KUSAKA, KIYOTO SHIGA, KATSUNORI KATAGIRI, DAISUKE SAITO, SHIN-ICHI OIKAWA, AYA IKEDA, KODAI TSUCHIDA, JUN MIYAGUCHI, YU OHASHI, HISANORI ARIGA and KOZO TANNO

Anticancer Research December 2022, 42 (12) 6047-6056; DOI: https://doi.org/10.21873/anticanres.16116
You have access
Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
TAKURO OKADA, TAKASHI MATSUKI, CHIHIRO FUSHIMI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TATSUYA ITO, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, KENJI HANYU, GO OMURA, HIDEKI TAKAHASHI, TAKU YAMASHITA, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA

Anticancer Research October 2022, 42 (10) 4907-4912; DOI: https://doi.org/10.21873/anticanres.15996
Open Access
Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes
CHRISTOFOROS CHRISTOFI, LEANDROS LAMNIS, ALEXANDRA STARK, HEIKE PALM, KLAUS RÖMER, THOMAS VOGT and JÖRG REICHRATH

Anticancer Research October 2022, 42 (10) 5049-5067; DOI: https://doi.org/10.21873/anticanres.16014
Open Access
The Role of Toll-like Receptors in Esophageal Cancer
SPYRIDON DAVAKIS, ALKISTIS KAPELOUZOU, THEODOROS LIAKAKOS, MARIA MPOURA, DIMITRIOS STERGIOU, STRATIGOULA SAKELLARIOU and ALEXANDROS CHARALABOPOULOS

Anticancer Research June 2022, 42 (6) 2813-2818; DOI: https://doi.org/10.21873/anticanres.15762
You have access
Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma
TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, YUSUKE AIHARA, KENJI HANYU, YUKIOMI KUSHIHASHI, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, YUKI HARADA, KAHO MOMIYAMA, TAKU YAMASHITA, GO OMURA, HIDEAKI TAKAHASHI, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA

Anticancer Research March 2022, 42 (3) 1607-1613; DOI: https://doi.org/10.21873/anticanres.15635

Main menu

User menu

Search

squamous cell carcinoma

Pages